Why is "Neuroblastoma" trending?
Latest news, Wikipedia summary, and trend analysis.
Trend Analysis
- Ranking position: #
- Date: 2026-03-20 06:41:54
This topic has appeared in the trending rankings 1 time(s) in the past year. While it does not trend frequently, its appearance suggests a renewed or concentrated surge of public interest.
Based on Wikipedia pageviews and search interest, this topic gained significant attention on the selected date.
Trend Insight
Neuroblastoma entered the ranking for the first time today at position #. This is its highest position ever recorded.
Trend History
This topic has appeared in the English Wikipedia rankings 1 time. It first appeared on 2026-03-20 and was most recently seen on 2026-03-20.
Wikipedia Overview
Neuroblastoma (NB) is a type of cancer that forms in certain types of nerve tissue. It most frequently starts from one of the adrenal glands but can also develop in the neck, chest, abdomen, or spine. Symptoms may include bone pain, a mass in the abdomen, neck, or chest, or painless bluish lumps under the skin.
Read more on Wikipedia →Related Topics
Trending Topic Today
Search Interest Perspective
-
How aggressive childhood cancer spreads: Researchers find new treatment targets for high-risk neuroblastoma - The University of Alabama at Birmingham
-
The PLK4 inhibitor RP-1664 demonstrates potent efficacy in neuroblastoma preclinical models through a dual mechanism of sensitivity - Nature
-
The B7-H3/CD3 immune phenotype identifies prognostic subgroups in neuroblastoma - Frontiers
-
Peptide-Based mRNA Vaccine Offers New Hope for Neuroblastoma Treatment - Inside Precision Medicine
-
Risk-adapted frameworks reshape pediatric neuroblastoma care - News-Medical
-
mRNA vaccine shows promise against childhood neuroblastoma cancer - Drug Target Review
-
Maria Antonietta De Ioris: Rethinking GD2 as a Dynamic Target in Neuroblastoma - Oncodaily
-
FDA Grants Fast Track Designation to Daretabart for High-Risk Neuroblastoma - CancerNetwork
-
New anticancer vaccine shows early success in targeting neuroblastoma - Medical Xpress
-
Flagship study uncovers how cancer cell stemness drives immune evasion in neuroblastoma - news.okstate.edu
-
FDA Grants Rare Pediatric Disease Designation to Opaganib for Neuroblastoma - Targeted Oncology
-
FOXR2-Mediated CNS Neuroblastoma in a Pediatric Patient Treated With Multimodal Therapy Including Proton Craniospinal Irradiation: A Case Report - Cureus
-
PP2A activation targets MYCN in neuroblastoma - Nature
-
Using the mathematics of quantum mechanics to improve neuroblastoma outcomes - News-Medical
-
Myeloid derived suppressor cells in neuroblastoma: mechanisms of immune evasion and therapeutic opportunities - Frontiers
-
Targeting replication stress in neuroblastoma by exploiting the synergistic potential of second generation RRM2 and CHK1 inhibitors | Cell Death & Disease - Nature
-
Concurrent naxitamab and lorlatinib in a patient with refractory high-risk neuroblastoma: a case report - Frontiers
-
Correction: An unexpected role for caspase-2 in neuroblastoma - Nature
-
CDK2 inhibition promotes neuronal differentiation in neuroblastoma - Nature
-
Dissecting neuroblastoma heterogeneity through single-cell multi-omics: insights into development, immunity, and therapeutic resistance | Oncogene - Nature
-
Dual lipid modulation overcomes ferroptosis resistance in high-risk neuroblastoma | Cell Death & Differentiation - Nature
-
Transcriptomic and epigenetic profiling of neuroblastoma states in response to RBM39 degrader - Nature
-
At St. Jude, Erma’s family turned cancer treatment into a year of celebration - St. Jude Children's Research Hospital
-
3-year-old girl battles return of stage 4 neuroblastoma after completing treatment - lex18.com
-
New mRNA vaccine shrinks neuroblastoma tumors in preclinical study - News-Medical
-
An Unusual Cause of Persistent Wheeze in Infancy: Intrathoracic Neuroblastoma of the Lower Thoracic Sympathetic Chain - Hamad - 2026 - Case Reports in Pulmonology - Wiley Online Library
-
New PET tracer show promise in neuroblastoma - AuntMinnie
-
A single enzyme keeps neuroblastoma alive. Researchers just learned how to shut it off - EurekAlert!
-
RedHill's Opaganib Receives FDA Rare Pediatric Disease Designation for Neuroblastoma in Addition to Current Orphan Drug Designation - PR Newswire
-
Neuroblastoma in neonates: a case report and literature review - Frontiers
-
Tri-State couple raises awareness after 2-year-old daughter’s neuroblastoma diagnosis - FOX19 | Cincinnati
-
'To hear our baby has cancer is world-shattering' - BBC
-
Targeted diet helps reprogram aggressive neuroblastoma in mice - News-Medical
-
DANEELpath open source digital analysis tools for histopathological research in neuroblastoma models - Nature
-
Scientists crack an 'undruggable' childhood cancer protein, opening a path to treatments for neuroblastoma - Medical Xpress
-
Efficacy of high-dose chemotherapy combined with hematopoietic stem cell transplantation in advanced neuroblastoma - Frontiers
-
Ethan’s rodeo returns for 17th year to benefit neuroblastoma research - WGEM
-
Target antigen–displaying extracellular vesicles boost CAR T cell efficacy in cell and mouse models of neuroblastoma - Science | AAAS
-
Neuroblastoma Tumor Growth in Mice Suppressed by Blocking Enzyme to Inhibit mTOR Signaling - genengnews.com
-
Romidepsin Identified as Candidate for Treating Relapsed Neuroblastoma - Inside Precision Medicine
-
2 Kentucky families find strength in each other as toddlers battle neuroblastoma - lex18.com
-
Lorlatinib Shows Promise in ALK Driven Neuroblastoma - EMJ
-
Orbital neuroblastoma: A tale of two children : Indian Journal of Ophthalmology - Case Reports - Ovid
-
Family finds support at St. Jude as 6-year-old battles neuroblastoma - WTVA
-
Study links food insecurity to tumor growth in pediatric neuroblastoma - Michigan Medicine
-
Coexpression of MYCN and ALK Induces Neuroblastoma-Like Tumors From Human iPS Cell-Derived Cranial Neural Crest Cells - Wiley Online Library
-
Machine learning identifies statin and phenothiazine combo for neuroblastoma treatment - Medical Xpress
-
Armored for Victory: Reprogramming CAR T Cells Against Neuroblastoma - American Association for Cancer Research (AACR)
-
Online fundraiser for 3-year-old Bryce, diagnosed with rare cancer, surpasses $16,000 goal - WHEC.com
-
Neuroblastoma Tumor Growth Slowed by High Levels of HIF2α - Inside Precision Medicine
-
2-year-old battles Neuroblastoma - WPSD Local 6
-
Molecular regulation and therapeutic targeting of MYCN in neuroblastoma: a comprehensive review - Frontiers
-
New drug combo for relapsed neuroblastoma shows promise in the lab - BioTechniques
-
Incidence and risk factors for postoperative pulmonary complications in children following surgery for retroperitoneal neuroblastoma - Frontiers
-
Risk-guided care reshapes childhood neuroblastoma treatment - 24-7 Press Release Newswire
-
Freddy E. Escorcia: Study Combining Radiopharmaceuticals and CAR T Cells Against Neuroblastoma - Oncodaily
-
RedHill's Opaganib Enhances Efficacy of Neuroblastoma Chemo Combination and Augment Anti-Tumor Immunity in Triple-Negative Breast Cancer in Preclinical Studies - New Data Presented at AACR 2026 - PR Newswire
-
Why Alex's Lemonade Stand Foundation has been “amazing” for this neuroblastoma patient - CBS News
-
Rare Occurrence of Congenital Neuroblastoma and Tuberous Sclerosis - ScienceDirect.com
-
Fractal Dimension of High-Risk Neuroblastoma Vascularity in MRI Is Associated with Chemotherapy Response and Event-Free Survival | Radiology: Imaging Cancer - RSNA Journals
-
Dinutuximab beta plus chemotherapy shrinks neuroblastoma tumors in children - News-Medical
-
Theo’s Story - Neuroblastoma UK
-
Renaissance Pharma Limited, an Essential Pharma company, secures FDA Fast Track Designation and IND clearance for Daretabart (hu1418K322A) in high-risk neuroblastoma - GlobeNewswire
-
Pediatric Neuroblastoma Treatment Market Outlook 2026-2030 & 2035 - United Therapeutics Corporation, APEIRON Biologics, Pfizer, Bayer, and Amgen Dominate - Yahoo Finance
-
New research reveals how subtle genetic differences shape neuroblastoma behaviour - The Institute of Cancer Research
-
How Alan Carr's Celebrity Traitors gift will help Neuroblastoma UK - BBC
-
Neuroblastoma Pipeline Accelerates as 20+ Pharma Companies Rigorously Develop Drugs for Market Entry | DelveInsight - Barchart.com
-
Primary CNS Neuroblastoma, FOXR2‐Activated: Clinicopathological Study of Two Cases With Immunohistochemical Characterization and Literature Review - Wiley Online Library
-
MSK Kids: Recent Research Advances for High-Risk Neuroblastoma - Memorial Sloan Kettering Cancer Center
-
Food insecurity linked to tumor growth in pediatric neuroblastoma - Medical Xpress
-
'I wasn't meant to live past one, now I'm running a half marathon' - BBC
-
Pediatric Neuroblastoma Treatment Market Outlook 2026-2030 - GlobeNewswire
-
Florence’s Story - Neuroblastoma UK
-
AMXT 1501 Plus Difluoromethylornithine Nets FDA Orphan Drug Designation in Neuroblastoma - onclive.com
-
Stanley’s Story - Neuroblastoma UK
-
New research suggests potential combination therapy option for children with neuroblastoma to prevent resistance to treatment - Neuroblastoma UK
-
Reprogramming neuroblastoma by diet-enhanced polyamine depletion - Nature
-
Late effects after high-risk neuroblastoma (LEAHRN): a multicentre, cross-sectional cohort study from the Children's Oncology Group - The Lancet
-
'A true Christmas miracle': Michigan troopers drive 600 miles to deliver gifts to toddler battling cancer - KSBW
-
Neuroblastoma developmental therapeutics research and discoveries - Children's Hospital of Philadelphia
-
Daily Dose - From a Grim Diagnosis to a Bright Future: Baylee’s Neuroblastoma Journey - Atrium Health
-
Frank’s Story - Neuroblastoma UK
-
mRNA vaccine shows potential in neuroblastoma - Medical Independent
-
Beat Childhood Cancer Research Consortium at Penn State College of Medicine and Aminex Therapeutics announce national clinical trial for pediatric patients with high-risk cancers - Penn State Health News
-
Research partly funded by Neuroblastoma UK leads to an innovative stem cell model providing insight into childhood cancer origins - Neuroblastoma UK
-
Woodland Park Recognizes September as Childhood, Ovarian Cancer Awareness Month - TAPinto
-
Smart blood test helps detect neuroblastoma relapse earlier - Prinses Maxima Centrum
-
Cell State Plasticity and Therapy Resistance in Neuroblastoma and Paraganglioma – Schlisio Lab - Karolinska Institutet
-
Longitudinal single-cell multiomic atlas of high-risk neuroblastoma reveals chemotherapy-induced tumor microenvironment rewiring - Nature
-
Lesion Analysis of 18F-Metafluorobenzylguanidine PET Imaging in Neuroblastoma - Journal of Nuclear Medicine
-
A swollen belly mistaken for weight gain: Doctor explains how neuroblastoma, a common cancer in children, - The Times of India
-
Bilateral Adrenal Mass Secondary to Bilateral Infantile Neuroblastoma in an Infant With Beckwith-Wiedemann Syndrome - Wiley Online Library
-
Semi-quantitative MIBG scores in relapsed/refractory neuroblastoma: Prognostic insights from post-131I-MIBG treatment scans and impact of SPECT-CT imaging - www.elsevier.com
-
Food insecurity impacts neuroblastoma pathogenesis in murine xenograft tumor models | Communications Biology - Nature
-
Targeted ferroptosis induction enhances chemotherapy efficacy in chemoresistant neuroblastoma - Nature
-
GD2-CART01 for Relapsed or Refractory High-Risk Neuroblastoma - NEJM
-
Neuroblastoma arises in early fetal development and its evolutionary duration predicts outcome - Nature
-
Olfactory neuroblastoma didn’t stop this survivor from achieving his goals - UT MD Anderson
-
Lauren's story - Neuroblastoma UK
-
Neuroblastoma plasticity during metastatic progression stems from the dynamics of an early sympathetic transcriptomic trajectory - Nature
Why This Topic Is Trending
This topic has recently gained attention due to increased public interest. Search activity and Wikipedia pageviews suggest growing global engagement.
Search Interest & Related Topics
Search interest data over the past 12 months indicates that this topic periodically attracts global attention. Sudden spikes often correlate with major news events, public statements, or geopolitical developments.